Kenmei develops solutions that apply artificial intelligence to analyze and optimize mobile networks globally. Their technologies aim to reduce energy consumption and automate network management to increase efficiency.
The startup plans to use the €4M raised to accelerate the evolution of their product by enhancing its AI capabilities and expanding their presence in the international market.
FitnessKPI offers a specialized analytics platform for the fitness industry, providing insights that help gyms and fitness centers optimize their operations. Their technology tracks and analyzes key performance indicators to help businesses improve customer engagement and operational efficiency.
The €1M raised will be invested in further development of their platform and expanding their reach in international markets.
Jelly Pills specializes in nutritional supplements in gummy form, offering an innovative way to maintain health. These products stand out for being vegan, organic, gluten-free, lactose-free, and cruelty-free, providing a healthy and accessible option for daily consumption.
The €1M raised will be used to expand their presence in the international market and bring their products to new consumers around the world.
Kreios Space develops technology that allows satellites to remain in very low Earth orbits (VLEO). This unique capability enables them to stay closer to Earth for extended periods, enhancing the efficiency and effectiveness of space operations.
With €2.3M in funding, the startup is set to advance its mission in the space sector. The resources will be used to intensify laboratory testing, develop new facilities, and expand the team.
Íkualo is a fintech startup focused on improving financial inclusion through innovative solutions that streamline banking processes. Its goal is to provide more accessible financial services for migrants by using technology to simplify and secure financial transactions.
Íkualo will use the €1M raised to continue developing its technology and expand its market presence. The fintech aims to reach 70K users in its first year, thus solidifying its commitment to increasing financial inclusion in these communities.
Café de Finca specializes in the production of sustainable coffee, focusing on ethical sourcing and environmental sustainability. The startup works directly with coffee growers to improve agricultural practices and ensure fair trade standards, enhancing the quality and sustainability of coffee production.
The €2.5M in funds will be used to strengthen their B2B approach by expanding their national presence, advancing their growth strategy in the Horeca channel, and in major retail chains.
Integra Therapeutics is developing innovative gene-editing therapies to cure genetic diseases. Their research leverages the latest advancements in gene therapy to create more effective and safer treatments for various conditions.
The €2.5M in funding will grant the startup will receive will fund the market preparation of the FiCAT platform, which focuses on engineering T cells and hematopoietic stem cells for the treatment of rare diseases, autoimmune disorders, and cancer.
Splight offers intelligent energy solutions aimed at reducing energy consumption and promoting sustainability. Their technology helps businesses and consumers optimize energy use, contributing to lower energy costs and reduced environmental impact.
The $12M raised will fund Splight’s expansion to improve the efficiency of electric power transmission and reduce grid limitations, particularly in integrating renewable energies into existing markets, thereby strengthening their presence and projects.
Widhoc is focused on developing technologies that enhance agricultural efficiency and reduce environmental impact. Their solutions aim to optimize water usage and increase crop productivity through data analysis and technical innovations.
The startup has secured €2M in its first funding round, which will be used to expand the company’s reach beyond national borders, with specific plans to establish operations in new international markets and strengthen their global presence.
The Blue Box has developed a device for the early detection of breast cancer using a non-invasive test that utilizes urine samples, offering a painless, radiation-free, and low-cost option.
The €500K raised will be used to conduct the necessary clinical trials for its approval and clinical use. The Blue Box aims to be available on the market by 2025, starting with its introduction in gynecological clinics in Spain, marking a significant step in its expansion and accessibility.
These startups are not only driving innovation but also transforming their industries with key investments for their growth and development. They are positioned to become leaders and shape the future of their respective fields.
